01—Abstract
Summary
Summary of the 10-Q filed July 25, 2024. Cited figures are marked; the original filing is the authoritative source.
Willis Towers Watson Public Limited Company reported higher second-quarter 2024 results, with revenue of $2,265 milliona, up from $2,159 million in the prior-year quarter.
Net income attributable to WTW was $141 millionb, compared with $94 million, and diluted earnings per share were $1.36, compared with $0.88. For the six months ended June 30, 2024, revenue was $4,606 million (versus $4,403 million), net income attributable to WTW was $331 million (versus $297 million), and diluted earnings per share were $3.20 (versus $2.77). The filing attributes the increases primarily to higher revenue in both the Health, Wealth & Career and Risk & Broking segments.
Organic revenue growth was 6% for the quarter and 5% for the six months. Adjusted measures also improved. Adjusted operating income was $385 millionc for the quarter (versus $315 million) and adjusted diluted earnings per share were $2.55 (versus $2.05).
Adjusted EBITDA was $466 milliond for the quarter (versus $411 million) and $1,034 million for the six months (versus $914 million). Management cited higher revenue, partly offset by higher incentive costs and salary expense. Net cash from operating activities was $431 million for the six months, and free cash flow, as the company defines it, was $361 million, compared with $350 million a year earlier.
On the balance sheet, the company issued $750 million of 5.900% senior notes due 2054 and used proceeds to repay $650 million of 3.600% senior notes at maturity. Total debt was $5,307 million at June 30, 2024, and the company had full access to its $1.5 billion revolving credit facility.
Management repurchased $301 million of shares in the first half and had approximately $1.0 billion remaining on its repurchase authority. The filing also notes the Transformation program, which the company expects to generate annual cost savings in excess of $450 million by the end of 2024, and the CMS 2025 Final Rule, which could affect compensation for its Medicare Advantage businesses.
02—Key points
Key Highlights
- Q2 2024 revenue was $2,265 million, up from $2,159 million, with organic revenue growth of 6%.
- Q2 2024 net income attributable to WTW was $141 million ($1.36 diluted EPS), versus $94 million ($0.88) in Q2 2023.
- Adjusted diluted EPS was $2.55 for Q2 2024 versus $2.05, and adjusted EBITDA was $466 million versus $411 million.
- Six-month net cash from operating activities was $431 million, and free cash flow was $361 million, up from $350 million.
- The company issued $750 million of 5.900% senior notes due 2054 and repaid $650 million of 3.600% senior notes due 2024; total debt stood at $5,307 million.
- Share repurchases totaled $301 million in the first six months, with approximately $1.0 billion of repurchase authority remaining; the quarterly dividend was $0.88 per share.
- The Transformation program is expected to generate annual cost savings in excess of $450 million by the end of 2024, with cumulative costs of approximately $1.045 billion.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ2 FY2024filed July 25, 2024Financial Statements
Q2 FY2024 against Q2 FY2023
| Line item | Q2 FY2024Q2 FY2023 | Change |
|---|---|---|
| Revenue | $2.27B$2.16B | +4.9% |
| Operating Expenses | $2.05B$2.02B | +1.8% |
| Operating Income | $212.00M$142.00M | +49.3% |
| Interest Expense | $68.00M$57.00M | +19.3% |
| Net Income | $141.00M$94.00M | +50.0% |
| EPS (Basic) | $1.37$0.88 | +55.7% |
| EPS (Diluted) | $1.36$0.88 | +54.5% |
| Shares Outstanding (Basic) | 103.00M107.00M | −3.7% |
| Shares Outstanding (Diluted) | 103.00M107.00M | −3.7% |
05—Questions
Frequently Asked Questions
How did WTW's revenue and profitability change in the second quarter of 2024?
Revenue rose to $2,265 million from $2,159 million, and net income attributable to WTW increased to $141 million from $94 million. Diluted EPS was $1.36 compared with $0.88. The filing attributes the increase primarily to higher revenue in both segments, partly offset by higher incentive costs and salary expense, increased interest expense and lower pension income.
What are WTW's adjusted results, and how do they differ from GAAP results?
Adjusted operating income was $385 million for Q2 2024 (versus $315 million), and adjusted diluted EPS was $2.55 (versus $2.05). Adjustments exclude amortization, restructuring costs, transaction and transformation costs, and a $13 million provision for a specified litigation matter. The filing describes these as non-GAAP measures that management uses to evaluate core operations.
How is WTW funding its operations, debt and shareholder returns?
Net cash from operating activities was $431 million for the six months ended June 30, 2024. The company issued $750 million of 5.900% senior notes due 2054, of which about $737 million was net proceeds, and used $662 million to repay the 3.600% notes. It repurchased $301 million of shares and paid $176 million in dividends. Cash and cash equivalents were $1,247 million, and the $1.5 billion revolving credit facility was fully available at June 30, 2024.
What is the Transformation program, and what savings does WTW expect?
The Transformation program, initiated in the fourth quarter of 2021, is designed to enhance operations, optimize technology and align the real estate footprint. WTW expects it to generate annual cost savings in excess of $450 million by the end of 2024, with cumulative costs of approximately $1.045 billion and capital expenditures of approximately $130 million. The company has identified $394 million of cumulative annualized run-rate savings to date.
What regulatory risks does the filing highlight for WTW's Medicare business?
The filing says the CMS 2025 Final Rule, issued April 4, 2024, restructures compensation paid to independent agents and brokers for Medicare Advantage and Part D, which may require changes to how WTW is paid and could negatively affect revenue. A federal court decision stayed portions of the rule, creating uncertainty. The filing also notes the DOL Retirement Security Rule, issued April 23, 2024, may expand fiduciary standards applicable to some of WTW's businesses.
06—Continue